Stock listing
A1W7EA Stock Price, News, Filings & Events — Veracyte, Inc.
Selected listing: A1W7EA · LSX · EUR · DE
This page tracks Veracyte, Inc.'s A1W7EA:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1W7EA:LSX. A1W7EA:LSX is the stock-level entry point for investors researching Veracyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Veracyte, Inc. (Ticker: VCYT) is a public company operating in the American market, with a market capitalization of approximately $4.5 billion. The company specializes in genomic diagnostics, providing innovative solutions to improve patient care. Veracyte focuses on advancing precision medicine through its advanced technologies and products.
- Ticker
- A1W7EA:LSX
- Asset type
- Stock
- Market cap
- $3.29B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSX
- Currency
- EUR
Veracyte, Inc. A1W7EA:LSX stock context
This page tracks Veracyte, Inc.'s A1W7EA:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1W7EA:LSX. A1W7EA:LSX is the stock-level entry point for investors researching Veracyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Veracyte, Inc. (Ticker: VCYT) is a public company operating in the American market, with a market capitalization of approximately $4.5 billion. The company specializes in genomic diagnostics, providing innovative solutions to improve patient care. Veracyte focuses on advancing precision medicine through its advanced technologies and products.
Latest news from Veracyte, Inc.
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
September 14, 2026
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Veracyte Announces Second Quarter 2026 Financial Results
July 30, 2026
Veracyte : to Release Second Quarter 2026 Financial Results on July 30, 2026
July 9, 2026
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
July 9, 2026
Veracyte, Inc. earnings calls
Veracyte, Inc. (VCYT) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Veracyte, Inc. (VCYT) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Veracyte, Inc. (VCYT) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Veracyte, Inc. (VCYT) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Veracyte, Inc. (VCYT) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Veracyte, Inc. (VCYT) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Veracyte, Inc.
Veracyte, Inc. investor report
Review AI stock analysis and investor report context for A1W7EA:LSX.
Veracyte, Inc. company profile
View the public company page for Veracyte, Inc. on 6ix.
Veracyte, Inc. news
Read company news and market updates connected to Veracyte, Inc..
Veracyte, Inc. investor events
Find investor webinars, events, and replay context for Veracyte, Inc..
Alternate listings
VCYT:NASDAQ
US · USD
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:GETTEX
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
VCYT:BOATS
US · USD
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
A1W7EA:LS
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:TRADEGATE
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:DUS
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:FWB
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:MUN
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:HAM
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.
12V:SWB
DE · EUR
Alternate listing for Veracyte, Inc.; the primary context on this page is A1W7EA:LSX.